How and Why Psychedelic Drugs Can Conquer The Mental Health Crisis

An enormous Crisis. Huge treatment markets. Massive disruption potential. Welcome to the psychedelic drug industry.

Read more
Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago

Field Trip Health opens a new clinic in Chicago, its 4th ketamine-assisted psychotherapy clinic.

Read more
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms

Numinus announces its first psilocybin harvest and the appointment of a new Science Officer.

Read more
Colorado marijuana vape aerosol testing rules address key health issues

As they respond to the 2019 vaping health crisis, Colorado marijuana regulators are believed to be among the first in the nation to require cannabis vaporizer companies to test the aerosol produced when the oil is heated into vapor.

Read more
The Challenge to Watch: Sisley, et al. v. DEA

With the evolution of the United States’ relationship with cannabis over recent decades, numerous parties have petitioned the U.S. Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. […]

The post The Challenge to Watch: Sisley, et al. v. DEA appeared first on Harris Bricken.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )